GOV.UK
Newborn blood spot screening data report published for 2016 to 2017
The annual newborn blood spot screening data collection and performance analysis report for the year 1 April 2016 to 31 March 2017.
laboratories
Primary HPV testing update
Ruth Stubbs, PHE's Cervical Screening Programme Manager, shares how the plans for introducing HPV primary screening are coming along.
Register now for sickle cell and thalassaemia screening laboratory update day
The NHS Sickle Cell and Thalassaemia Screening Programme has organised 2 laboratory update days in April.
Improving quality in Down’s, Edwards’ and Patau’s screening laboratories
Shared learning in this blog post is specifically aimed at laboratories that provide Down’s, Edwards’ and Patau’s screening.
New guidance to help cervical screening providers reduce cytology backlogs
PHE Screening has published guidance for laboratories and local cervical screening providers to support the option of mitigating against the risk of longer cytology backlogs by using primary HPV screening pilot sites.
HPV primary screening implementation: NHS England announces next steps
NHS England has published a statement regarding commissioning decisions for HPV primary screening in the cervical screening programme.
Sickle cell and thalassaemia screening handbook for antenatal laboratories updated
We’re pleased to announce the publication of an updated version of the antenatal laboratory handbook for the NHS Sickle Cell and Thalassaemia (SCT) Screening Programme.
EQA (external quality assessment) in cervical screening: what's it all about?
The breast, bowel and cervical screening programmes require consultant pathologists and other specialist laboratory staff to take part in ‘external quality assessment’ or EQA. But what is EQA exactly?
PHE and NHS England join forces to help cervical screening laboratories clear backlogs
Cervical screening prevents cancer by detecting abnormalities of the cervix and referring women for potential treatment.
Addition of non-invasive test to improve screening for pregnant women
A new test will be added to the fetal anomaly screening pathway following an announcement by the Department of Health.